Intestinal lesions produced by prednisolone: prevention (cytoprotection) by 16,16-dimethyl prostaglandin E2.
D000818:Animals; D001414:Bacitracin / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D005260:Female; D009355:Neomycin / Q000627:therapeutic use; D011112:Polymyxin B / Q000627:therapeutic use; D011239:Prednisolone / Q000009:adverse effects*; D011458:Prostaglandins E / Q000627:therapeutic use*; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced / Q000517:prevention & control; D013997:Time Factors
D011458:Prostaglandins E; D001414:Bacitracin; D011239:Prednisolone; D009355:Neomycin; D011112:Polymyxin B